Trade Groups Call for Tighter Drug Distribution Rules FINAL Edition

William K. Hubbard, FDA senior associate commissioner, yesterday characterized the PDA recommendations as "a step forward. In most cases, they embody the kinds of questions that we believe wholesalers should be asking of their suppliers and the kinds of requirements that wholesalers should be i...

Full description

Saved in:
Bibliographic Details
Published inThe Washington post
Main Author Mary Pat Flaherty and Gilbert M. Gaul
Format Newspaper Article
LanguageEnglish
Published Washington, D.C WP Company LLC d/b/a The Washington Post 04.12.2003
Online AccessGet full text

Cover

More Information
Summary:William K. Hubbard, FDA senior associate commissioner, yesterday characterized the PDA recommendations as "a step forward. In most cases, they embody the kinds of questions that we believe wholesalers should be asking of their suppliers and the kinds of requirements that wholesalers should be imposing on people." The HDMA called for all states to inspect a wholesaler applicant's site before issuing a license. Most states do not perform an inspection before issuing a license, HDMA staff found. Both groups called for wholesalers to tighten their scrutiny of prior sales records, particularly when an invoice shows three prior sales. The HDMA also called for more extensive sales histories on high-priced items particularly attractive to counterfeiters. The enhanced histories would be tracked back to a drugmaker. Current rules say that the sales are tracked only to a manufacturer's authorized distributor, which can mask some sales.
ISSN:0190-8286